# Pascal Vranckx

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pascal-vranckx/

## Facts

| Field | Value |
| --- | --- |
| Citations | 73,763 |
| Field | Antiplatelet Therapy and Cardiovascular Diseases |
| h-index | 85 |
| i10-index | 217 |
| Last Known Institution | Jessa Hospital |
| OpenAlex ID | https://openalex.org/A5059011787 |
| ORCID iD | https://orcid.org/0000-0002-1526-0652 |
| Works | 740 |

## Researcher papers

Showing 12 of 15.

- [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation](https://scholariq.org/papers/2017-esc-guidelines-for-the-management-of-acute-myocardial-infarction-in/)
- [2018 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2018-esc-eacts-guidelines-on-myocardial-revascularization/)
- [Clinical End Points in Coronary Stent Trials](https://scholariq.org/papers/clinical-end-points-in-coronary-stent-trials/)
- [2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation](https://scholariq.org/papers/2020-esc-guidelines-for-the-management-of-acute-coronary-syndromes-in-patients/)
- [2023 ESC Guidelines for the management of acute coronary syndromes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-acute-coronary-syndromes/)
- [Standardized Bleeding Definitions for Cardiovascular Clinical Trials](https://scholariq.org/papers/standardized-bleeding-definitions-for-cardiovascular-clinical-trials/)
- [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS](https://scholariq.org/papers/2017-esc-focused-update-on-dual-antiplatelet-therapy-in-coronary-artery-disease/)
- [Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium](https://scholariq.org/papers/standardized-endpoint-definitions-for-transcatheter-aortic-valve-implantation/)
- [2018 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2018-esc-eacts-guidelines-on-myocardial-revascularization-2/)
- [Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document](https://scholariq.org/papers/standardized-end-point-definitions-for-coronary-intervention-trials-the-academic/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial](https://scholariq.org/papers/ticagrelor-plus-aspirin-for-1-month-followed-by-ticagrelor-monotherapy-for-23/)

## Researcher topics

- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Jessa Hospital](https://scholariq.org/institutions/jessa-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.